サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439628

眼科機器 - 世界市場の考察、競合情勢、市場予測（2030年）

Ophthalmic Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
眼科機器 - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の眼科機器の市場規模は、2023年に559億1,000万米ドル、2030年までに712億3,000万米ドルに達し、2024年～2030年の予測期間にCAGRで4.12%の成長が見込まれます。眼科機器の需要は主に、近視の有病率の上昇と老年人口基盤の拡大によって後押しされており、その結果、さまざまな病因による眼疾患の有病率が増加し、眼科手術の件数が増加し、製品開発における技術革新が進み、製品需要の増加が見込まれるため、2024年～2030年の予測期間に眼科機器市場の成長に寄与します。

眼科機器の市場力学

眼科機器市場は、多くの理由によって製品需要が増加しており、重要な特徴の1つは老年人口の増加です。世界人口の高齢化に関する国連のレポートによると、2020年に世界で65歳以上の人口が約7億2,700万人になります。前述の資料はさらに、老年人口は30年間で15億人以上に倍増すると予測しています。老年人口は、緑内障、白内障、加齢黄斑変性などのさまざまな眼科疾患を発症しやすいです。その結果、加齢に関連した眼疾患の有病率が増加しています。さらに、世界保健機関が提供したデータによると、2020年に770万人が緑内障と診断され、420万人が角膜混濁と診断されました。したがって、眼疾患のタイムリーな診断を促進し、必要な治療を行うことで疾患の進行を抑制するために眼科機器の需要が増加しており、結果として世界の眼科機器市場の成長につながっています。

眼科機器の需要に影響を与えるもう1つの重要な特徴は、近視の有病率の上昇です。International Myopia Institute（2023）が提供したデータによると、2050年までに全世界で約50億人の近視患者が発生し、10億人近くが強度近視の患者人口を構成すると推定されています。近視が世界中で失明の主な原因となっていることは、多くの研究で報告されています。

さらに、近視は網膜剥離、白内障、緑内障などの眼の合併症のリスクを高めることが示されています。したがって、世界中で近視の有病率が上昇していることは、眼科機器に対する需要の増加をさらに助長し、予測期間の世界の眼科機器市場の成長を後押しすると見込まれます。

さらに、イメージングチップやコンピューター処理能力の向上などの技術の進歩は、眼球のイメージングに大きな進歩をもたらすのに役立っています。AIと眼科機器の統合は、疾患の診断と治療において開業医にとって有益なもう1つの技術の進歩です。

しかし、媒体の混濁、モーションアーチファクト、画像処理、誤った色の表示などの画質の影響のような機器に関連する制約や、特に新興経済国における熟練した専門家の限られた利用可能性が、眼科機器市場の成長にとっての課題となっています。

眼科機器市場のセグメント分析

眼科機器市場の製品セグメントの診断・モニタリング機器カテゴリでは、診断・モニタリング機器カテゴリの光コヒーレンストモグラフィベースの画像診断機器が、予測期間に眼科機器市場で大きなシェアを占める見込みです。これは、スキャン速度、非侵襲性、3Dデータの生成など、光コヒーレンストモグラフィ技術に関連する利点が、旧来の方法よりも優れているためと考えられます。走査型レーザー検眼鏡（SLO）や眼底写真に基づく従来の血管造影法とは異なり、OCT血管造影技術は深さ情報を提供し、網膜のすべての血管層と選択された脈絡膜層の分離を可能にします。

さらに、スペクトルドメインOCTのような新しいOCT機器の開発により、毎秒何万ものAスキャンを取得できるようになり、真の3Dイメージングを日常的に行うことができるようになりました。その結果、3D OCTは現在広く臨床で使用され、標準治療となっています。

従って、OCTイメージング機器の絶え間ない技術の進歩と、その他の製品タイプに対する追加の利点が、眼科機器市場の成長を押し上げると予測されます。

当レポートでは、世界の眼科機器市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 眼科機器市場レポートのイントロダクション

第2章 眼科機器市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価
  • 財務ベンチマーク

第3章 規制と特許の分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 眼科機器市場の主な要因の分析

  • 眼科機器市場の促進要因
    • 近視の有病率の上昇
    • 老年人口基盤の拡大
    • 眼科手術の増加
    • 製品開発における技術革新
  • 眼科機器市場の抑制要因と課題
    • 各機器の制限
    • 新興国では熟練した専門家の確保が限られている
  • 眼科機器市場の機会
    • 新興経済国の市場参入企業の注目の高まり
    • 技術固有の制限への対処

第5章 眼科機器市場のポーターのファイブフォース分析

第6章 眼科機器市場に対するCOVID-19の影響分析

第7章 眼科機器市場のレイアウト

  • 製品タイプ別
    • 手術機器
    • 診断・モニタリング機器
    • レンズ
  • 用途別
    • 緑内障
    • 白内障
    • 網膜症
    • 加齢黄斑変性
    • 近視
    • その他
  • エンドユーザー別
    • 病院
    • 専門クリニック
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 眼科機器市場：世界の企業シェア分析 - 主要3～5社

第9章 眼科機器市場の企業と製品のプロファイル

  • ZEISS Group
  • Leica Microsystems
  • CANON MEDICAL SYSTEMS EUROPE B.V.
  • Optovue Incorporated
  • Heidelberg Engineering Inc
  • NIDEK CO. LTD.
  • Luneau Technology Group
  • OPTOPOL Technology Sp. z o.o
  • Sonomed Escalon
  • Keeler
  • Konan Medical USA, Inc
  • TOMEY Corporation
  • Rexxam Co. Ltd.
  • HAAG-STREIT GROUP
  • Essilor Instruments USA Ltd.
  • Ziemer Ophthalmic Systems
  • Costruzione Strumenti Oftalmici
  • Topcon Corporation
  • HAI Laboratories Inc
  • Centervue SpA
  • HOYA Corporation
  • Bausch & Laumb Incorporated
  • CooperVision Inc
  • Alcon Inc
  • Rudolf Riester GmbH
  • Johnson & Johnson Vision Care, Inc.
  • Hill-Rom Services, Inc
  • Hanita Lenses
  • Takagi Seiko
  • STAAR Surgical

第10章 KOLの見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1 Competitive Analysis
  • Table 2 COVID-19 Impact Analysis on Ophthalmic Devices Market
  • Table 3 Ophthalmic Devices Market in Global (2021-2030)
  • Table 4 Ophthalmic Devices Market in Global by Product Type (2021-2030)
  • Table 5 Ophthalmic Devices Market in Global by Application (2021-2030)
  • Table 6 Ophthalmic Devices Market in Global by End User (2021-2030)
  • Table 7 Ophthalmic Devices Market in Global by Geography (2021-2030)
  • Table 8 Ophthalmic Devices Market in North America (2021-2030)
  • Table 9 Ophthalmic Devices Market in North America by Product Type (2021-2030)
  • Table 10 Ophthalmic Devices Market in North America by Application (2021-2030)
  • Table 11 Ophthalmic Devices Market in North America by End User (2021-2030)
  • Table 12 Ophthalmic Devices Market in North America by Country (2021-2030)
  • Table 13 Ophthalmic Devices Market in the US (2021-2030)
  • Table 14 Ophthalmic Devices Market in Canada (2021-2030)
  • Table 15 Ophthalmic Devices Market in Mexico (2021-2030)
  • Table 16 Ophthalmic Devices Market in Europe (2021-2030)
  • Table 17 Ophthalmic Devices Market in Europe by Product Type (2021-2030)
  • Table 18 Ophthalmic Devices Market in Europe by Application (2021-2030)
  • Table 19 Ophthalmic Devices Market in Europe by End User (2021-2030)
  • Table 20 Ophthalmic Devices Market in Europe by Country (2021-2030)
  • Table 21 Ophthalmic Devices Market in France (2021-2030)
  • Table 22 Ophthalmic Devices Market in Germany (2021-2030)
  • Table 23 Ophthalmic Devices Market in the United Kingdom (2021-2030)
  • Table 24 Ophthalmic Devices Market in Italy (2021-2030)
  • Table 25 Ophthalmic Devices Market in Spain (2021-2030)
  • Table 26 Ophthalmic Devices Market in Russia (2021-2030)
  • Table 27 Ophthalmic Devices Market in Rest of Europe (2021-2030)
  • Table 28 Ophthalmic Devices Market in APAC (2021-2030)
  • Table 29 Ophthalmic Devices Market in APAC by Product Type (2021-2030)
  • Table 30 Ophthalmic Devices Market in APAC by Application (2021-2030)
  • Table 31 Ophthalmic Devices Market in APAC by End User (2021-2030)
  • Table 32 Ophthalmic Devices Market in APAC by Country (2021-2030)
  • Table 33 Ophthalmic Devices Market in China (2021-2030)
  • Table 34 Ophthalmic Devices Market in Japan (2021-2030)
  • Table 35 Ophthalmic Devices Market in India (2021-2030)
  • Table 36 Ophthalmic Devices Market in Australia (2021-2030)
  • Table 37 Ophthalmic Devices Market in South Korea (2021-2030)
  • Table 38 Ophthalmic Devices Market in Rest of APAC (2021-2030)
  • Table 39 Ophthalmic Devices Market in Rest of World (2021-2030)
  • Table 40 Ophthalmic Devices Market in RoW by Product Type (2021-2030)
  • Table 41 Ophthalmic Devices Market in RoW by Application (2021-2030)
  • Table 42 Ophthalmic Devices Market in RoW by End User (2021-2030)
  • Table 43 Ophthalmic Devices Market in RoW by Region (2021-2030)
  • Table 44 Ophthalmic Devices Market in Middle East (2021-2030)
  • Table 45 Ophthalmic Devices Market in Africa (2021-2030)
  • Table 46 Ophthalmic Devices Market in South America (2021-2030)

List of Figures

Figures 1 Competitive Analysis

Figures 2 COVID-19 Impact Analysis on Ophthalmic Devices Market

Figures 3 Ophthalmic Devices Market in Global (2021-2030)

Figures 4 Ophthalmic Devices Market in Global by Product Type (2021-2030)

Figures 5 Ophthalmic Devices Market in Global by Application (2021-2030)

Figures 6 Ophthalmic Devices Market in Global by End User (2021-2030)

Figures 7 Ophthalmic Devices Market in Global by Geography (2021-2030)

Figures 8 Ophthalmic Devices Market in North America (2021-2030)

Figures 9 Ophthalmic Devices Market in North America by Product Type (2021-2030)

Figures 10 Ophthalmic Devices Market in North America by Application (2021-2030)

Figures 11 Ophthalmic Devices Market in North America by End User (2021-2030)

Figures 12 Ophthalmic Devices Market in North America by Country (2021-2030)

Figures 13 Ophthalmic Devices Market in the US (2021-2030)

Figures 14 Ophthalmic Devices Market in Canada (2021-2030)

Figures 15 Ophthalmic Devices Market in Mexico (2021-2030)

Figures 16 Ophthalmic Devices Market in Europe (2021-2030)

Figures 17 Ophthalmic Devices Market in Europe by Product Type (2021-2030)

Figures 18 Ophthalmic Devices Market in Europe by Application (2021-2030)

Figures 19 Ophthalmic Devices Market in Europe by End User (2021-2030)

Figures 20 Ophthalmic Devices Market in Europe by Country (2021-2030)

Figures 21 Ophthalmic Devices Market in France (2021-2030)

Figures 22 Ophthalmic Devices Market in Germany (2021-2030)

Figures 23 Ophthalmic Devices Market in the United Kingdom (2021-2030)

Figures 24 Ophthalmic Devices Market in Italy (2021-2030)

Figures 25 Ophthalmic Devices Market in Spain (2021-2030)

Figures 26 Ophthalmic Devices Market in Russia (2021-2030)

Figures 27 Ophthalmic Devices Market in Rest of Europe (2021-2030)

Figures 28 Ophthalmic Devices Market in APAC (2021-2030)

Figures 29 Ophthalmic Devices Market in APAC by Product Type (2021-2030)

Figures 30 Ophthalmic Devices Market in APAC by Application (2021-2030)

Figures 31 Ophthalmic Devices Market in APAC by End User (2021-2030)

Figures 32 Ophthalmic Devices Market in APAC by Country (2021-2030)

Figures 33 Ophthalmic Devices Market in China (2021-2030)

Figures 34 Ophthalmic Devices Market in Japan (2021-2030)

Figures 35 Ophthalmic Devices Market in India (2021-2030)

Figures 36 Ophthalmic Devices Market in Australia (2021-2030)

Figures 37 Ophthalmic Devices Market in South Korea (2021-2030)

Figures 38 Ophthalmic Devices Market in Rest of APAC (2021-2030)

Figures 39 Ophthalmic Devices Market in Rest of World (2021-2030)

Figures 40 Ophthalmic Devices Market in RoW by Product Type (2021-2030)

Figures 41 Ophthalmic Devices Market in RoW by Application (2021-2030)

Figures 42 Ophthalmic Devices Market in RoW by End User (2021-2030)

Figures 43 Ophthalmic Devices Market in RoW by Region (2021-2030)

Figures 44 Ophthalmic Devices Market in Middle East (2021-2030)

Figures 45 Ophthalmic Devices Market in Africa (2021-2030)

Figures 46 Ophthalmic Devices Market in South America (2021-2030)

Figures 47 Market Drivers

Figures 48 Market Barriers

Figures 49 Marker Opportunities

Figures 50 PORTER'S Five Force Analysis

目次
Product Code: DIMDCL0464

Ophthalmic Devices Market By Product Type (Surgical Devices [ Phacoemulsification Devices, Ophthalmic Viscoelastic Devices, Glaucoma Drainage Devices, Vitrectomy Systems, Excimer Lasers, Photocoagulation Lasers, And Others], Diagnostic And Monitoring Devices [Optical Coherence Tomography Systems, Ophthalmic Ultrasound Systems, Fundus Cameras, Slit Lamps, Corneal Topography Systems, And Others], Lenses [Intraocular Lenses, Contact Lenses {Soft Contact Lenses, Rigid Gas Permeable Contact Lenses}, Spectacle Lenses, And Others], And Others), By Application (Glaucoma, Cataract, Retinopathies, Age-Related Macular Degeneration, Myopia, And Others), By End User (Hospitals, Specialty Clinics, And Others), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to increasing prevalence of myopia and rising geriatric population resulting in rising prevalence of ocular diseases.

Global Ophthalmic Devices Market was valued at USD 55.91 billion in 2023, growing at a CAGR of 4.12% during the forecast period from 2024 to 2030 to reach USD 71.23 billion by 2030. The demand for ophthalmic devices is primarily being boosted by the rising prevalence of myopia and growing geriatric population base which has resulted in the increased prevalence of ocular diseases of different etiologies, increasing number of ophthalmic surgeries, and technical innovation in product development which are expected to increase in the product demand thereby contributing in the growth of the ophthalmic devices market during the forecast period from 2024-2030.

Ophthalmic Devices Market Dynamics:

The ophthalmic devices market is witnessing an increase in product demand owing to numerous reasons and one of the key aspects being the rise in the geriatric population. According to the United Nations Report on the aging global population, there were about 727 million people over the age of 65 worldwide in 2020. The aforementioned source further mentioned that the elderly population is expected to double more than 1.5 billion in three decades. The elderly population is highly susceptible to the development of various ophthalmic diseases such as glaucoma, cataract, and age-related macular degeneration among others. This in turn has led to the increasing prevalence of age-related ocular diseases. Furthermore, as per the data provided by the World Health Organization, in 2020, 7.7 million people were diagnosed with glaucoma and 4.2 million people were diagnosed with corneal opacities. Therefore, in order to facilitate the timely diagnosis of ocular diseases and restrict the disease progression by administering necessary treatments, ophthalmic devices are witnessing an increase in demand, ultimately leading to the global ophthalmic devices market growth.

Another key aspect influencing the demand for ophthalmic equipment is the rising prevalence of myopia. As per the data provided by the International Myopia Institute (2023), the estimates suggest that by 2050, there will be approximately 5 billion cases of myopia across the globe and nearly one billion people constituting the patient population for high myopia by 2050. It has been reported in many studies that myopia is becoming a leading cause of blindness across the globe.

Furthermore, myopia has shown to heighten the risk for other ocular complications such as retinal detachment, cataracts, and glaucoma. Therefore, the rising prevalence of myopes across the globe is further expected to aid in the increasing demand for ophthalmic devices, thereby boosting the growth of the global ophthalmic devices market during the forecast period.

Moreover, technological advancements such as improvements in imaging chips and computer processing power have been instrumental in bringing about major advances in imaging of the eye. The integration of artificial intelligence with the ophthalmic devices has been another technological advancement that has been beneficial for practitioners in disease diagnoses and treatment.

However, limitations associated with equipment such as the susceptibility of image quality to media opacities, motion artifact and image processing and the presentation of false color along with the limited availability of skilled professionals specifically in emerging economies may prove to be challenging factors for the ophthalmic devices market growth.

Ophthalmic Devices Market Segment Analysis:

Ophthalmic Devices Market by Product Type (Surgical Devices [Phacoemulsification Devices, Ophthalmic Viscoelastic Devices, Glaucoma Drainage Devices, Vitrectomy Systems, Excimer Lasers, Photocoagulation Lasers, and Others], Diagnostic and Monitoring Devices [Optical Coherence Tomography Systems, Ophthalmic Ultrasound Systems, Fundus Cameras, Slit Lamps, Corneal Topography Systems, and Others], Lenses [Intraocular Lenses, Contact Lenses {Soft Contact Lenses, Rigid Gas Permeable Contact Lenses}, Spectacle Lenses, and Others], and Others), by Application (Glaucoma, Cataract, Retinopathies, Age-Related Macular Degeneration, Myopia, and Others), by End User (Hospitals, Specialty Clinics, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the diagnosis and monitoring devices category of the product segment of the Ophthalmic Devices Market, the Ophthalmic Coherence Tomography-based imaging equipment of the diagnostic and monitoring equipment category is estimated to hold a significant share in the ophthalmic devices market during the forecast period. This can be ascribed to the advantages associated with the Optical Coherence Tomography technology such as scan speed, non-invasive nature, and the generation of the three-dimensional data over older methods. Unlike conventional angiography methods based on scanning laser ophthalmoscopy (SLO) or fundus photography, OCT-Angiography techniques provide depth information and allow the isolation of all the vascular layers of the retina and the layers selected choroidal layers.

Additionally, the development of newer OCT devices- such as spectral-domain OCT, tens of thousands of A-scans can be acquired each second, which enables true 3-D imaging a routine practice. Consequently, 3-D OCT is now in wide clinical use and has become the standard of care.

Therefore, the constant technological advancements coupled with added advantages of the OCT imaging equipment among other product types is expected to boost the growth of the ophthalmic devices market.

North America is expected to dominate the Overall Ophthalmic Devices Market:

Among all the regions, North America is expected to account for the significant market revenue share in the ophthalmic devices market. North America is expected to dominate the global market and would continue to maintain its dominance in revenue generation in the ophthalmic devices market during the forecast period. This domination is attributed to the increasing prevalence of ocular diseases, the rising geriatric population in the region, increasing prevalence of lifestyle disorders such as diabetes, obesity, and hypertension that lead to the development of various ocular diseases, and rising government initiatives for creating awareness regarding prevalence of ophthalmic diseases and treatment are expected to aid in the growth of the North America ophthalmic devices market.

As per the National Diabetics Statistics Report published by the Centers for Disease Control and Prevention (CDC) in 2020, near about 34.2 million Americans were diabetic in 2020. The report further stated that approximately 88 million Americans showed pre-diabetes levels. As per the CDC itself, diabetes is considered as one of the major risk factors that may lead to the development of various ocular diseases such as glaucoma, diabetic retinopathy, and cataracts among others. With the high presence of diabetic population in the country, it is estimated that there may be an increase in the patient population suffering from ocular diseases of different etiologies that may in turn drive the demand for ophthalmic devices for both diagnostics and treatment purposes, thereby driving the North America ophthalmic devices market growth during the forecast period and eventually contributing in the overall growth of the ophthalmic devices market.

In addition to the above-mentioned factor, according to the data provided by the Centers for Disease Control and Prevention, in 2018, approximately 116 million people in the United States suffered from hypertension. Hypertension is considered to be one of the key risk factors for the development of ocular diseases such as cataracts and glaucoma among others. Therefore, the presence of large patient population suffering from hypertension correlates to the presence of a high patient population suffering from the progression of these diseases which would indicate the growing need for ophthalmic devices that are employed in disease diagnoses as well as treatment. Therefore, the points mentioned above will collectively contribute in the growing demand for ophthalmic devices in the region which in turn will motivate key market players in widening their market reach in the North America region.

Ophthalmic Devices Market Key Players:

Some of the key market players operating in the ophthalmic devices market includes ZEISS Group, Leica Microsystems, CANON MEDICAL SYSTEMS EUROPE B.V., Optovue, Incorporated, Heidelberg Engineering Inc, NIDEK CO., LTD, Luneau Technology Group, OPTOPOL Technology Sp. z o.o., Sonomed Escalon, Keeler, Konan Medical USA, Inc., TOMEY CORPORATION, Rexxam Co. Ltd., HAAG-STREIT GROUP, Essilor Instruments USA Ltd, Ziemer Ophthalmic Systems, Costruzione Strumenti Oftalmici, Topcon Corporation, HAI Laboratories, Inc., Centervue SpA, HOYA Corporation, Bausch & Laumb Incorporated, Coopervision Inc, Alcon Inc, Rudolf Riester GmbH, Johnson & Johnson Vision Care, Inc, Hill-Rom Services, Inc, Hanita Lenses, Takagi Seiko, STAAR Surgical and others.

Recent Developmental Activities in Ophthalmic Devices Market:

In October 2022, NIDEK CO LTD. launched the Retina Scan Duo 2, a combined OCT and fundus camera system. The system comes equipped with new features designed to enhance screening and clinical efficiency, in addition to user-friendly features that were incorporated from the previous model.

In October 2022, iCare USA received the 510k approval from the US Food and Drug Administration for their EIDON Ultra-Widefield Lens module which is capable of capturing 120 degrees images of the retina in a single shot or in mosaic function mode, images up to 200 degrees.

In May 2022, Essilor International received the product approval from the US FDA for their product Essilor Stellest which is a spectacle lens developed for the correction of myopia and slowing down myopia progression in children.

Key Takeaways from the Ophthalmic Devices Market Report Study

Market size analysis for current ophthalmic devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the ophthalmic devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Ophthalmic Devices Market.

Various opportunities available for the other competitor in the Ophthalmic Devices Market space.

What are the top performing segments in 2023? How these segments will perform in 2030?

Which is the top-performing regions and countries in the current ophthalmic devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for ophthalmic devices market growth in the coming future?

Target Audience who can be benefited from this Ophthalmic Devices Market Report Study

Ophthalmic Devices products providers

Research organizations and consulting companies

Ophthalmic Devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in ophthalmic devices

Various End-users who want to know more about the Ophthalmic Devices market and latest technological developments in the Ophthalmic Devices market.

Frequently Asked Questions for Ophthalmic Devices Market:

1. What are Ophthalmic Devices?

Ophthalmic devices help in the diagnosis and treatment of ocular diseases by helping in the visualization of the anatomy of eye and treating the indication in by being utilized in different aspects of disease diagnosis and treatment.

2. What is the market for Global Ophthalmic Devices?

Global Ophthalmic Devices Market was valued at USD 55.91 billion in 2023, growing at a CAGR of 4.12% during the forecast period from 2024 to 2030 to reach USD 71.23 billion by 2030.

3. What are the drivers for Global Ophthalmic Devices Market?

The demand for ophthalmic devices is primarily being boosted by the rising prevalence of myopia and growing geriatric population base which has resulted in the increased prevalence of ocular diseases of different etiologies, increasing number of ophthalmic surgeries, and technical innovation in product development which are expected to increase in the product demand thereby contributing in the growth of the ophthalmic devices market during the forecast period from 2024-2030.

4. Who are the key players operating in Global Ophthalmic Devices Market?

Some of the key market players operating in the ophthalmic devices market includes ZEISS Group, Leica Microsystems, CANON MEDICAL SYSTEMS EUROPE B.V., Optovue, Incorporated, Heidelberg Engineering Inc, NIDEK CO., LTD, Luneau Technology Group, OPTOPOL Technology Sp. z o.o., Sonomed Escalon, Keeler, Konan Medical USA, Inc., TOMEY CORPORATION, Rexxam Co. Ltd., HAAG-STREIT GROUP, Essilor Instruments USA Ltd, Ziemer Ophthalmic Systems, Costruzione Strumenti Oftalmici, Topcon Corporation, HAI Laboratories, Inc., Centervue SpA, HOYA Corporation, Bausch & Laumb Incorporated, Coopervision Inc, Alcon Inc, Rudolf Riester GmbH, Johnson & Johnson Vision Care, Inc, Hill-Rom Services, Inc, Hanita Lenses, Takagi Seiko, STAAR Surgical and others.

5. Which region has the highest share in Ophthalmic Devices market?

North America is expected to dominate the overall Ophthalmic Devices market during the forecast period, 2024 to 2030. Owing to significant growth factors such as rising prevalence cataracts due to the increasing prevalence of diabetes, hypertension, obesity, and the aging population, rising government initiatives regarding creating awareness about ocular diseases are expected to aid in the growth of the North America Ophthalmic Devices Market. Furthermore, high disposable income, sophisticated healthcare infrastructure, and new product approvals also propelled the market growth in this region.

Table of Contents

1.Ophthalmic Devices Market Report Introduction

2.Ophthalmic Devices Market Executive Summary

  • 2.1 Scope of the Study
  • 2.2 Market at Glance
  • 2.3 Competitive Assessment
  • 2.4 Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1 The United States
  • 3.2 Europe
  • 3.3 Japan
  • 3.4 China

4. Ophthalmic Devices Market Key Factors Analysis

  • 4.1 Ophthalmic Devices Market Drivers
    • 4.1.1 Rising Prevalence of Myopia
    • 4.1.2 Growing Geriatric Population Base
    • 4.1.3 Increasing Number of Ophthalmic Surgeries
    • 4.1.4 Technical Innovation in Product Development
  • 4.2 Ophthalmic Devices Market Restraints and Challenges
    • 4.2.1 Limitations of Respective Devices
    • 4.2.2 Limited Availability of Skilled Professionals in Emerging Economies
  • 4.3 Ophthalmic Devices Market Opportunities
    • 4.3.1 Increasing Focus of Market Players in Emerging Economies
    • 4.3.2 Addressing the Technology-Specific Limitations

5. Ophthalmic Devices Market Porter's Five Forces Analysis

  • 5.1 Bargaining Power of Suppliers
  • 5.2 Bargaining Power of Consumers
  • 5.3 Threat of New Entrants
  • 5.4 Threat of Substitutes
  • 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Ophthalmic Devices Market

7. Ophthalmic Devices Market Layout

  • 7.1 By Product Type
    • 7.1.1 Surgical Devices
      • 7.1.1.1 Phacoemulsification Devices
      • 7.1.1.2 Ophthalmic Viscoelastic Devices
      • 7.1.1.3 Glaucoma Drainage Devices
      • 7.1.1.4 Vitrectomy Systems
      • 7.1.1.5 Excimer Lasers
      • 7.1.1.6 Photocoagulation Lasers
      • 7.1.1.7 Others
    • 7.1.2 Diagnostic and Monitoring Devices
      • 7.1.2.1 Optical Coherence Tomography Systems
      • 7.1.2.2 Ophthalmic Ultrasound Systems
      • 7.1.2.3 Fundus Cameras
      • 7.1.2.4 Slit Lamps
      • 7.1.2.5 Corneal Topography Systems
      • 7.1.2.6 Others
    • 7.1.3 Lenses
      • 7.1.3.1 Soft Contact Lenses
      • 7.1.3.1.1 Soft Contact Lenses
      • 7.1.3.1.2 Rigid Gas Permeable Lenses
      • 7.1.3.2 Spectacle Lenses
      • 7.1.3.3 Others
  • 7.2 By Application
    • 7.2.1 Glaucoma
    • 7.2.2 Cataracts
    • 7.2.3 Retinopathies
    • 7.2.4 Age-related Macular Degeneration
    • 7.2.5 Myopia
    • 7.2.5 Others
  • 7.3 By End User
    • 7.3.1 Hospitals
    • 7.3.2 Specialty Clinics
    • 7.3.3 Others
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 North America Ophthalmic Devices Market, by Product Type
      • 7.4.1.2 North America Ophthalmic Devices Market, by Application
      • 7.4.1.2 North America Ophthalmic Devices Market, by End User
      • 7.4.1.4 North America Ophthalmic Devices Market, by Country
      • 7.4.1.4.1 United States
      • 7.4.1.4.2 Canada
      • 7.4.1.4.3 Mexico
    • 7.4.2 Europe
      • 7.4.2.1 Europe Ophthalmic Devices Market, by Product Type
      • 7.4.2.2 Europe Ophthalmic Devices Market, by Application
      • 7.4.2.2 Europe Ophthalmic Devices Market, by End User
      • 7.4.2.4 Europe Ophthalmic Devices Market, by Country
      • 7.4.2.4.1 France
      • 7.4.2.4.2 Germany
      • 7.4.2.4.3 United Kingdom
      • 7.4.2.4.4 Italy
      • 7.4.2.4.5 Spain
      • 7.4.2.2.6 Russia
      • 7.4.2.2.7 Rest of Europe
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 Asia-Pacific Ophthalmic Devices Market, by Product Type
      • 7.4.3.2 Asia-Pacific Ophthalmic Devices Market, by Application
      • 7.4.3.2 Asia-Pacific Ophthalmic Devices Market, by End User
      • 7.4.3.4 Asia-Pacific Ophthalmic Devices Market, by Country
      • 7.4.3.4.1 China
      • 7.4.3.4.2 Japan
      • 7.4.3.4.3 India
      • 7.4.3.4.4 Australia
      • 7.4.3.4.5 South Korea
      • 7.4.3.4.6 Rest of Asia Pacific
    • 7.4.4 Rest of the World (RoW)
      • 7.4.4.1 RoW Ophthalmic Devices Market, by Product Type
      • 7.4.4.2 RoW Ophthalmic Devices Market, by Application
      • 7.4.4.2 RoW Ophthalmic Devices Market, by End User
      • 7.4.4.4 RoW Ophthalmic Devices Market, by Region
      • 7.4.4.4.1 Middle East
      • 7.4.4.4.2 Africa
      • 7.4.4.4.3 South America

8. Ophthalmic Devices Market Global Company Share Analysis - Key 3-5 Companies

9. Ophthalmic Devices Market Company and Product Profiles

  • 9.1 ZEISS Group
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4 Product Listing
    • 9.1.5. Entropy
  • 9.2 Leica Microsystems
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4 Product Listing
    • 9.2.5. Entropy
  • 9.3 CANON MEDICAL SYSTEMS EUROPE B.V.
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4 Product Listing
    • 9.3.5. Entropy
  • 9.4 Optovue Incorporated
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4 Product Listing
    • 9.4.5. Entropy
  • 9.5 Heidelberg Engineering Inc
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4 Product Listing
    • 9.5.5. Entropy
  • 9.6 NIDEK CO. LTD.
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4 Product Listing
    • 9.6.5. Entropy
  • 9.7 Luneau Technology Group
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4 Product Listing
    • 9.7.5. Entropy
  • 9.8 OPTOPOL Technology Sp. z o.o
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4 Product Listing
    • 9.8.5. Entropy
  • 9.9 Sonomed Escalon
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4 Product Listing
    • 9.9.5. Entropy
  • 9.10 Keeler
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4 Product Listing
    • 9.10.5. Entropy
  • 9.11 Konan Medical USA, Inc
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4 Product Listing
    • 9.11.5. Entropy
  • 9.12 TOMEY Corporation
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4 Product Listing
    • 9.12.5. Entropy
  • 9.13 Rexxam Co. Ltd.
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4 Product Listing
    • 9.13.5. Entropy
  • 9.14 HAAG-STREIT GROUP
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4 Product Listing
    • 9.14.5. Entropy
  • 9.15 Essilor Instruments USA Ltd.
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4 Product Listing
    • 9.15.5. Entropy
  • 9.16 Ziemer Ophthalmic Systems
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4 Product Listing
    • 9.16.5. Entropy
  • 9.17 Costruzione Strumenti Oftalmici
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4 Product Listing
    • 9.17.5. Entropy
  • 9.18 Topcon Corporation
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4 Product Listing
    • 9.18.5. Entropy
  • 9.19 HAI Laboratories Inc
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4 Product Listing
    • 9.19.5. Entropy
  • 9.20 Centervue SpA
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4 Product Listing
    • 9.20.5. Entropy
  • 9.21 HOYA Corporation
    • 9.21.1. Company Overview
    • 9.21.2. Company Snapshot
    • 9.21.3. Financial Overview
    • 9.21.4 Product Listing
    • 9.21.5. Entropy
  • 9.22 Bausch & Laumb Incorporated
    • 9.22.1. Company Overview
    • 9.22.2. Company Snapshot
    • 9.22.3. Financial Overview
    • 9.22.4 Product Listing
    • 9.22.5. Entropy
  • 9.23 CooperVision Inc
    • 9.23.1. Company Overview
    • 9.23.2. Company Snapshot
    • 9.23.3. Financial Overview
    • 9.23.4 Product Listing
    • 9.23.5. Entropy
  • 9.24 Alcon Inc
    • 9.24.1. Company Overview
    • 9.24.2. Company Snapshot
    • 9.24.3. Financial Overview
    • 9.24.4 Product Listing
    • 9.24.5. Entropy
  • 9.25 Rudolf Riester GmbH
    • 9.25.1. Company Overview
    • 9.25.2. Company Snapshot
    • 9.25.3. Financial Overview
    • 9.25.4 Product Listing
    • 9.25.5. Entropy
  • 9.26 Johnson & Johnson Vision Care, Inc.
    • 9.26.1. Company Overview
    • 9.26.2. Company Snapshot
    • 9.26.3. Financial Overview
    • 9.26.4 Product Listing
    • 9.26.5. Entropy
  • 9.27 Hill-Rom Services, Inc
    • 9.27.1. Company Overview
    • 9.27.2. Company Snapshot
    • 9.27.3. Financial Overview
    • 9.27.4 Product Listing
    • 9.27.5. Entropy
  • 9.28 Hanita Lenses
    • 9.28.1. Company Overview
    • 9.28.2. Company Snapshot
    • 9.28.3. Financial Overview
    • 9.28.4 Product Listing
    • 9.28.5. Entropy
  • 9.29 Takagi Seiko
    • 9.29.1. Company Overview
    • 9.29.2. Company Snapshot
    • 9.29.3. Financial Overview
    • 9.29.4 Product Listing
    • 9.29.5. Entropy
  • 9.30 STAAR Surgical
    • 9.30.1. Company Overview
    • 9.30.2. Company Snapshot
    • 9.30.3. Financial Overview
    • 9.30.4 Product Listing
    • 9.30.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us